Jose M. Jurado
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
Journal: Journal for immunotherapy of cancer
Published: January 01, 2026
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
Journal: Oncoimmunology
Published: August 08, 2025
Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical medicine
Published: March 01, 2025
Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Journal: The British journal of dermatology
Published: December 14, 2022
Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.
Journal: Molecular oncology
Published: July 21, 2020
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
Journal: Molecular oncology
Published: June 28, 2020
Immunophenotypic Conversion between Primary and Relapse Breast Cancer and its Effects on Survival.
Journal: Gynecologic and obstetric investigation
Published: May 08, 2019
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 31, 2018
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.
Journal: Oncology letters
Published: January 01, 2014
Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report.
Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report.
Journal: Oncology letters
Published: November 19, 2012
Last Updated: 09/26/2026